You have to be joking Roby Zomer with the following “…to position Argent BioPharma inpioneering drug discovery within the biopharmaceutical sector, supported by the strengthening of ourmanagement team and advisory board”.
1. Your company and affiliates has NOT produced ANY pioneering drug discoveries. Most things you touch fails, is costly and lacks business acumen.
2. You haven’t delivered ANY product of real commercial value.
3. You’re haven’t delivered ANY sustainable revenue streams or markets, distribution partnerships or IP.
4. You haven’t delivered on Quarterly Reports ie Malta production facility operating - a complete failure and false statement amongst many other things.
5. You and your cronies - ex director Mitchell and Co have bleed (IMHO) or swindled the company dry for a decade or more at shareholders expense. You and others have presided over a sinking SP, countless CR’s and corporate, including financial restructuring producing NO tangible outcomes, poorly designed or more truthfully, no consistent sales, marketing and distribution plans, no final completion of products, no shareholder feedback on clinical trials and on, and on, and on it goes. You have put your hand out and given nothing in return. The company has bitten the hand that feeds it way, way too often.
6. I hope ASIC and the ASX take a close look at how this company is being managed, how, where, when and why shareholder money has been spent and whether ASX rules have been complied too and the corporations law upheld. Perhaps retail investors consider a class action.
- Forums
- ASX - By Stock
- RGT
- Ann: Argent BioPharma Appointments UK Corporate Broker
Ann: Argent BioPharma Appointments UK Corporate Broker, page-3
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.0¢ |
Change
-0.015(2.65%) |
Mkt cap ! $26.62M |
Open | High | Low | Value | Volume |
56.5¢ | 56.5¢ | 55.0¢ | $2.105K | 3.789K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4959 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 2662 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4959 | 0.505 |
1 | 5950 | 0.500 |
1 | 1000 | 0.470 |
1 | 2000 | 0.450 |
1 | 25000 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.570 | 2662 | 2 |
0.575 | 650 | 1 |
0.650 | 45000 | 1 |
0.700 | 1368 | 1 |
0.740 | 350 | 1 |
Last trade - 11.12am 09/10/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online